InsidersTradesSigma
MicroPort CardioFlow Medtech Corporation - B: insider trades · Hong Kong · HKEX
HKEX:microport-cardioflow-medtech-corporation-bHK·HKEXMcap 2.6Bn€Healthcare
Discover the full insider trade history of MicroPort CardioFlow Medtech Corporation - B, a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, MicroPort CardioFlow Medtech Corporation - B has logged 4 insider filings. Market capitalisation: €2.6bn. The latest transaction was disclosed on 15 May 2026 (Sale). Among the most active insiders: WANSTOK PHILIPPE. Every trade is openly available.
4
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
€345,612
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.02 €
Analyst consensus
2 analysts6.22 €Target 7.03 €(+248%)7.84 €
Income statement
Revenue57.0 M€
Gross profit37.1 M€65% margin
Net income−18.8 M€-33.0% margin
Valuation
P/Book1.3x
Beta0.33
Balance sheet & cash
Market cap2.57 Bn€
Total debt232.2 M€
Free Cash Flow−38.3 M€
Debt / Equity91%
Profitability & ownership
ROE-6.7%
ROA-2.4%
% insiders49.2%
% institutions21.0%
Last declaration on 15 May 2026
Declarations4 total
Executives●Sale6HKEX
€113,038400,000 shares@ €0.28260.0044% mcap32.7% of flow
ShareXHKG
HKEX:DA20260515E00004·
Executives●Sale7HKEX
€121,271400,000 shares@ €0.30320.0047% mcap35.1% of flow
ShareXHKG
HKEX:DA20260511E00419·
Executives●Sale6HKEX
€111,303339,000 shares@ €0.32830.0043% mcap32.2% of flow
ShareXHKG
HKEX:DA20260508E00632·
Executives●Purchase3HKEX
143,920 shares
ShareXHKG
HKEX:DA20260426E00009·
Ideal exit: 26 Dec 2026 (T+270)
4 of 4 declarations